Abstract
A Randomized, Double-Blind, Phase 2a Study to Evaluate the Tolerability, Feasibility, and Efficacy of AKST1210 in Patients on Hemodialysis with ESRD and Cognitive Impairment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have